Showing results (311-320 of 639) with videos related to
Sort By:
Pageof 64
Arthritis & Rheumatology (Hoboken, N.J.)|March 19, 2016
Risk of Herpes Zoster in Autoimmune and Inflammatory Diseases: Implications for VaccinationHuifeng Yun, Shuo Yang, Lang Chen, et al.Journal of Racial and Ethnic Health Disparities|February 13, 2019
Race Plays a Role in the Knowledge, Attitudes, and Beliefs of Women with OsteoporosisNicole C Wright, Mary E Melton, Maira Sohail, et al.Arthritis Care & Research|April 5, 2012
Rheumatoid arthritis disease activity measures: American College of Rheumatology recommendations for use in clinical practiceJaclyn Anderson, Liron Caplan, Jinoos Yazdany, et al.The Journal of Rheumatology|April 17, 2013
Clinical response within 12 weeks as a predictor of future low disease activity in patients with early RA: results from the TEAR TrialJeffrey R Curtis, Theresa McVie, Ted R Mikuls, et al.Arthritis Care & Research|August 7, 2025
Heterogeneity of Rheumatoid Arthritis-Associated Interstitial Lung Disease by Longitudinal Forced Vital Capacity Trajectory and Associations with Disease OutcomesBryant R England, Yangyuna Yang, Punyasha Roul, et al.Arthritis Research & Therapy|September 15, 2010
Development of a macromolecular prodrug for the treatment of inflammatory arthritis: mechanisms involved in arthrotropism and sustained therapeutic efficacyLing-dong Quan, P Edward Purdue, Xin-ming Liu, et al.Rheumatology (Oxford, England)|March 22, 2018
The subgingival microbiome in patients with established rheumatoid arthritisTed R Mikuls, Clay Walker, Fang Qiu, et al.Rheumatology (Oxford, England)|February 4, 2014
Association of rheumatoid arthritis susceptibility gene with lipid profiles in patients with rheumatoid arthritisLisa A Davis, Emily Whitfield, Grant W Cannon, et al.Pharmacoepidemiology and Drug Safety|December 19, 2023
Extracting forced vital capacity from the electronic health record through natural language processing in rheumatoid arthritis-associated interstitial lung diseaseBryant R England, Punyasha Roul, Yangyuna Yang, et al.The Journal of Rheumatology|June 3, 2009
Once-weekly oral alendronate 70 mg in patients with glucocorticoid-induced bone loss: a 12-month randomized, placebo-controlled clinical trialS Aubrey Stoch, Kenneth G Saag, Maria Greenwald, et al.Pageof 64